rs41274068

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_032776.3(JMJD1C):​c.1949C>T​(p.Thr650Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0119 in 1,613,936 control chromosomes in the GnomAD database, including 161 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T650T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0086 ( 9 hom., cov: 32)
Exomes 𝑓: 0.012 ( 152 hom. )

Consequence

JMJD1C
NM_032776.3 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.27

Publications

10 publications found
Variant links:
Genes affected
JMJD1C (HGNC:12313): (jumonji domain containing 1C) The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
JMJD1C Gene-Disease associations (from GenCC):
  • 22q11.2 deletion syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Illumina
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00345847).
BP6
Variant 10-63214218-G-A is Benign according to our data. Variant chr10-63214218-G-A is described in ClinVar as Benign. ClinVar VariationId is 460226.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 1310 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JMJD1CNM_032776.3 linkc.1949C>T p.Thr650Ile missense_variant Exon 8 of 26 ENST00000399262.7 NP_116165.1 Q15652-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JMJD1CENST00000399262.7 linkc.1949C>T p.Thr650Ile missense_variant Exon 8 of 26 5 NM_032776.3 ENSP00000382204.2 Q15652-1
JMJD1CENST00000542921.5 linkc.1403C>T p.Thr468Ile missense_variant Exon 7 of 25 1 ENSP00000444682.1 Q15652-3
JMJD1CENST00000402544.5 linkn.1921C>T non_coding_transcript_exon_variant Exon 5 of 22 1

Frequencies

GnomAD3 genomes
AF:
0.00864
AC:
1314
AN:
152160
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00294
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00367
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00310
Gnomad FIN
AF:
0.0177
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0132
Gnomad OTH
AF:
0.00908
GnomAD2 exomes
AF:
0.00874
AC:
2178
AN:
249102
AF XY:
0.00878
show subpopulations
Gnomad AFR exome
AF:
0.00239
Gnomad AMR exome
AF:
0.00333
Gnomad ASJ exome
AF:
0.00417
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0185
Gnomad NFE exome
AF:
0.0127
Gnomad OTH exome
AF:
0.00909
GnomAD4 exome
AF:
0.0123
AC:
17906
AN:
1461658
Hom.:
152
Cov.:
33
AF XY:
0.0120
AC XY:
8705
AN XY:
727142
show subpopulations
African (AFR)
AF:
0.00251
AC:
84
AN:
33480
American (AMR)
AF:
0.00344
AC:
154
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00429
AC:
112
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.00325
AC:
280
AN:
86254
European-Finnish (FIN)
AF:
0.0174
AC:
927
AN:
53280
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
0.0142
AC:
15762
AN:
1111940
Other (OTH)
AF:
0.00954
AC:
576
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
987
1973
2960
3946
4933
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
588
1176
1764
2352
2940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00860
AC:
1310
AN:
152278
Hom.:
9
Cov.:
32
AF XY:
0.00880
AC XY:
655
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.00294
AC:
122
AN:
41562
American (AMR)
AF:
0.00360
AC:
55
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4832
European-Finnish (FIN)
AF:
0.0177
AC:
188
AN:
10602
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0132
AC:
900
AN:
68004
Other (OTH)
AF:
0.00851
AC:
18
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
66
133
199
266
332
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0115
Hom.:
40
Bravo
AF:
0.00773
TwinsUK
AF:
0.0181
AC:
67
ALSPAC
AF:
0.0135
AC:
52
ESP6500AA
AF:
0.00266
AC:
10
ESP6500EA
AF:
0.0132
AC:
108
ExAC
AF:
0.00858
AC:
1037
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

JMJD1C: BP4, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Early myoclonic encephalopathy Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0071
.;T;.
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.18
FATHMM_MKL
Benign
0.66
D
LIST_S2
Uncertain
0.86
D;D;D
MetaRNN
Benign
0.0035
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
.;L;.
PhyloP100
2.3
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.0
.;N;N
REVEL
Benign
0.022
Sift
Uncertain
0.020
.;D;D
Sift4G
Benign
0.21
.;T;T
Polyphen
0.12
.;B;.
Vest4
0.18, 0.19
MVP
0.36
MPC
0.085
ClinPred
0.0081
T
GERP RS
3.1
Varity_R
0.034
gMVP
0.10
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41274068; hg19: chr10-64973978; COSMIC: COSV99062895; COSMIC: COSV99062895; API